Apex Science & Engineering Corp.

TWSE:3052 Voorraadrapport

Marktkapitalisatie: NT$2.4b

Apex Science & Engineering Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Apex Science & Engineering.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Construction winstgroei15.7%
Inkomstengroein/a
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

None

Laatst bijgewerktn/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Apex Science & Engineering (TWSE:3052) Will Pay A Dividend Of NT$0.40

Aug 10
Apex Science & Engineering (TWSE:3052) Will Pay A Dividend Of NT$0.40

The Return Trends At Apex Science & Engineering (TWSE:3052) Look Promising

Aug 07
The Return Trends At Apex Science & Engineering (TWSE:3052) Look Promising

Apex Science & Engineering's (TWSE:3052) Conservative Accounting Might Explain Soft Earnings

Mar 22
Apex Science & Engineering's (TWSE:3052) Conservative Accounting Might Explain Soft Earnings

Investors Aren't Buying Apex Science & Engineering Corp.'s (TPE:3052) Earnings

Apr 07
Investors Aren't Buying Apex Science & Engineering Corp.'s (TPE:3052) Earnings

Apex Science & Engineering Corp.'s (TPE:3052) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Mar 19
Apex Science & Engineering Corp.'s (TPE:3052) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

What Can The Trends At Apex Science & Engineering (TPE:3052) Tell Us About Their Returns?

Feb 26
What Can The Trends At Apex Science & Engineering (TPE:3052) Tell Us About Their Returns?

Is It Worth Buying Apex Science & Engineering Corp. (TPE:3052) For Its 4.1% Dividend Yield?

Feb 05
Is It Worth Buying Apex Science & Engineering Corp. (TPE:3052) For Its 4.1% Dividend Yield?

Apex Science & Engineering (TPE:3052) Seems To Use Debt Quite Sensibly

Jan 19
Apex Science & Engineering (TPE:3052) Seems To Use Debt Quite Sensibly

Did You Miss Apex Science & Engineering's (TPE:3052) 53% Share Price Gain?

Jan 01
Did You Miss Apex Science & Engineering's (TPE:3052) 53% Share Price Gain?

Is Apex Science & Engineering Corp.'s (TPE:3052) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Dec 14
Is Apex Science & Engineering Corp.'s (TPE:3052) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Should You Use Apex Science & Engineering's (TPE:3052) Statutory Earnings To Analyse It?

Nov 26
Should You Use Apex Science & Engineering's (TPE:3052) Statutory Earnings To Analyse It?

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Apex Science & Engineering onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

TWSE:3052 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (TWD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/20243,2731962,1072,109N/A
3/31/20243,4702091,5021,506N/A
12/31/20233,4842051,2331,236N/A
9/30/20233,374213-1,524-1,521N/A
6/30/20233,232224-1,046-1,038N/A
3/31/20232,950210141148N/A
12/31/20222,952207397403N/A
9/30/20222,780174604610N/A
6/30/20222,896123827828N/A
3/31/20223,507111444445N/A
12/31/20213,615103543545N/A
9/30/20213,975986062N/A
6/30/20214,875233440443N/A
3/31/20215,4633701,0341,035N/A
12/31/20205,218316783785N/A
9/30/20208,7765213,5443,546N/A
6/30/20207,4933693,4483,450N/A
3/31/20205,8601782,1942,197N/A
12/31/20195,6241752,4342,437N/A
9/30/20191,105-91-859-856N/A
6/30/20191,035-109-1,959-1,957N/A
3/31/20191,018-144-2,622-2,622N/A
12/31/20181,071-136-2,806-2,804N/A
9/30/20182,02089-2,157-2,155N/A
6/30/20182,803125-2,403-2,400N/A
3/31/20183,126186N/A-470N/A
12/31/20173,901201N/A589N/A
9/30/20174,02745N/A860N/A
6/30/20173,80142N/A2,149N/A
3/31/20173,61945N/A623N/A
12/31/20162,88844N/A-503N/A
9/30/20162,35761N/A-742N/A
6/30/20162,30892N/A-1,254N/A
3/31/20162,440137N/A-1,411N/A
12/31/20152,514143N/A-1,463N/A
9/30/20153,099192N/A-2,124N/A
6/30/20152,855121N/A-1,956N/A
3/31/20153,14641N/A-1,901N/A
12/31/20143,692186N/A-207N/A
9/30/20147,2241,143N/A2,150N/A
6/30/20148,6241,369N/A3,264N/A
3/31/20148,6221,406N/A3,679N/A
12/31/20138,1761,253N/A1,982N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if 3052's forecast earnings growth is above the savings rate (1%).

Winst versus markt: Insufficient data to determine if 3052's earnings are forecast to grow faster than the TW market

Hoge groeiwinsten: Insufficient data to determine if 3052's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if 3052's revenue is forecast to grow faster than the TW market.

Hoge groei-inkomsten: Insufficient data to determine if 3052's revenue is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if 3052's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven